Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This stock can't seem to hold any gains.
Nice trade MJ,,,I was lucky enuf to get 34-47.
FAS is better than nothing. Up 1.60 today.
This thing wants 50 today. It could happen!
Too bad there's not a banking sector 3x ETF. Those bank stocks are hitting new 52 week highs due to the optimism about Trump election. BAC is up to $20 from like 14 last week.
Y, me too. I'm hoping for 30 pts before I sell at my 60 targ.
Powerful move underway here. Still holding.
I hear ya. For what it's worth I'm holding this for an undetermined number of days or possibly weeks because I believe biotechs are in for a big relief rally since Hillary didn't get elected. She's the reason for the recent pullback in the sector but you probably already knew that.
That being said, yes it's risky to hold overnight but since we are both up a few dollars from our entries it's a little bit better than if it closed where you bought it.
LABU is at my first target and if it breaks to upside then my target 2 is in play at 56ish,,,see prev. post/chart.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125977962
In at 38 with a small position. Is this worth holding overnight? Skeptical about holding anything right now.
Would be like the epic run that the mining stocks had in early to mid 2016. Some of the leveraged ETFs provided 1,000%+ gains. I don't expect that here but it's fun to think about.
That would be incredible
can it get back to it's high over 90?
Wow I bought a small lot at $38 this morning. Wasn't sure how much more upside there was today...weeeee! Let's go back over $50!
You're lookin at it bruddah!
where's the bottom?
$LABU With elections comming, Bios earnings out will be skyrocketing, LABU will see close to $100.00 > its only $30.00 what a steal RATED BUY AND HOLD $LABU $$$$$
FWIW,,,LABU,,,My take on targets for LABU, which is very oversold.
Also bear in mind that the NASI(Nasdaq Summation) is also very oversold and due for a meaningfull bounce soon.
NASI:
http://stockcharts.com/h-sc/ui?s=%24NASI&p=D&yr=1&mn=0&dy=0&id=p32098005733
LABU Targets:
http://tos.mx/63tvbj
IMHO
I'm in at 34.40,,,10/20.
LABU should go back over 40 soon!
LABU is an ETF: The Direxion Daily S&;P. Biotech Bull 3x Fund (NYSEARCA: LABU) is an exchange-traded fund (ETF) that seeks to replicate 300% of the daily performance of its underlying index, the S&;P. Biotechnology Select Industry Index
this stock seems to be falling hard.
Rebought LABU yesterday, and added today. Waiting for 40's...
Watching for one more sell off today. If it happens, I may jump in. Daily RSI ready to hit 30
LABU is now above $51.76 per share.
Go LABU
Link: About LABU
http://www.direxioninvestments.com/products/daily-sp-biotech-bull-3x-shares
Go LABU
Back in at 39.56
Very bullish
LABD is getting way oversold and it should be inplay soon for a nice spike
which of the 2? they move in opposite directions.
LABD/LABU inplay soon
Sweet, thinking labd could look interesting in a dew days
Bottom tomorrow ~
nice play. Looks like still more room to run too.
Sold all my LABU today @ 37.15 for a 10+ point 40% three week gain!
Added LABU 26.53's today.
FWIW, split next week:
"Direxion Announces Reverse and Forward Share Splits of Ten Leveraged ETFs
Google+ Share with LinkedIn
Direxion ETFs | Funds
Direxion ETFs | Funds
NEW YORK, Feb. 19, 2016 /PRNewswire/ -- Direxion has announced it will execute reverse share splits for eight of its leveraged exchange-traded funds ("ETFs"), as well as forward share splits for another two leveraged ETFs. The total market value of the shares outstanding will not be affected as a result of these splits, except with respect to the redemption of fractional shares, as outlined below.
Eight Reverse Splits
Direxion will execute a 1-for-10 reverse split of the shares of the Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares and Direxion Daily Natural Gas Related Bull 3X Shares, effective at the open of the market on March 24, 2016. The firm will also execute a 1-for-4 reverse split of the Direxion Daily India Bull 3X Shares, Direxion Daily S&P Biotech Bull 3X Shares, Direxion Daily Brazil Bull 3X Shares, Direxion Daily Latin America Bull 3X Shares, Direxion Daily Emerging Markets Bull 3X Shares, and Direxion Daily Russia Bull 3X Shares, effective at the open of the market on March 24, 2016.
A summary of the eight ETFs undergoing reverse splits is as follows (please note the CUSIP changes, effective March 24, 2016):
(charts do not cut/paste)
As a result of this reverse split, every 10 or four shares of a Fund will be exchanged for one share as indicated in the table above. Accordingly, the total number of the issued and outstanding shares for the Funds will decrease by the approximate percentage indicated above. In addition, the per-share net asset value ("NAV") and next day's opening market price will be approximately 10 or four times higher for the Funds. Shares of the Funds will begin trading on NYSE Arca, Inc. ("NYSE Arca") on a split-adjusted basis on March 24, 2016 (the "Effective Date").
The next day's opening market value of the Funds' issued and outstanding shares, and thus a shareholder's investment value, will not be affected by the reverse split. The tables below illustrate the effect of a hypothetical 1-for-10 and 1-for-4 reverse split anticipated for the Funds, as applicable and described above:
Hypothetical example of 1-for-10 Reverse Split
As a result of these share splits, shareholders of each Fund will receive an additional four shares for each share held of the applicable Fund as indicated in the table above. Accordingly, the number of each Fund's issued and outstanding shares will increase by approximately 400% as indicated above.
All forward share splits will apply to shareholders of record as of the close of the NYSE Arca on March 22, 2016 (the "Record Date"), payable after the close of the NYSE Arca on March 23, 2016 (the "Payable Date"). Shares of the Funds will begin trading on the NYSE Arca on a split-adjusted basis on March 24, 2016 (the "Ex-Date"). On the Ex-Date, the opening market value of each Fund's issued and outstanding shares, and thus a shareholder's investment value, will not be affected by the share split. However, the per-share NAV and opening market price on the Ex-Date will be approximately one-fourth and one-half for the Funds. The tables below illustrate the effect of a hypothetical four-for-one share split on a shareholder's investment.
Hypothetical Example of 4-for-1 Forward Share Split
The Trust's transfer agent will notify the Depository Trust Company ("DTC") of the reverse and forward splits and instruct the DTC to adjust each shareholder's investment(s) accordingly. DTC is the registered owner of the Funds' shares and maintains a record of the Funds' record owners.
Redemption of Fractional Shares and Tax Consequences for Each Reverse and Forward Split
As a result of the reverse or forward split, a shareholder of a Fund's shares could potentially hold a fractional share. However, fractional shares cannot trade on the NYSE Arca. Thus, a Fund will redeem for cash a shareholder's fractional shares at the Fund's split-adjusted NAV as of the Record Date. Such redemption may have tax implications for those shareholders and a shareholder could recognize a gain or loss in connection with the redemption of the shareholder's fractional shares. Otherwise, the reverse or forward split will not result in a taxable transaction for holders of Fund shares. No transaction fee will be imposed on shareholders for such redemption.
"Odd Lot" Unit
Also as a result of the reverse or forward split, the Funds will have outstanding one aggregation of less than 50,000 shares to make a creation unit, or an "odd lot unit." Thus, the Funds will provide one authorized participant with a one-time opportunity to redeem the odd lot unit at the split-adjusted NAV or the NAV on such date the authorized participant seeks to redeem the odd lot unit.
About Direxion Investments:
Direxion builds bold products for investors who want more than the status quo. Our index-based products deliver directional options, magnified exposure, and long-term, rules-based strategies. Founded in 1997, the company has approximately $9.2 billion in assets under management as of December 31, 2015. Direxion's diverse suite of products helps investors navigate today's ever-changing markets. For more information, please visit www.direxioninvestments.com.
There is no guarantee that the funds will achieve their objectives.
For more information on all Direxion Shares daily leveraged ETFs, go to direxioninvestments.com, or call us at 866-476-7523.
The ETFs are not suitable for all investors and should be utilized only by investors who understand the risks associated with seeking daily leveraged investment results, and intend to actively monitor and manage their investments. Due to the daily nature of the leverage employed, there is no guarantee of amplified long-term returns. Past performance is not indicative of future results.
An investor should consider the investment objectives, risks, charges, and expenses of Direxion ETFs carefully before investing. The prospectus and summary prospectus contains this and other information about Direxion ETFs. Download a prospectus and summary prospectus at direxioninvestments.com. The prospectus and summary prospectus should be read carefully before investing.
Risks:
An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are non-diversified and include risks associated with concentration risk that results from the Funds' investments in a particular industry or sector which can increase volatility. The use of derivatives such as futures contracts, forward contracts, options and swaps are subject to market risks that may cause their price to fluctuate over time. The Fund does not attempt to, and should not be expected to, provide returns which are a multiple of the return of the Index for periods other than a single day. For other risks including leverage, correlation, compounding, market volatility and specific risks regarding each sector, please read the prospectus.
Distributor: Foreside Fund Services, LLC.
CONTACT:
James Doyle
JCPR
973-850-7308
jdoyle@jcprinc.com
SOURCE Direxion
RELATED LINKS
http://www.direxioninvestments.com
_____________________________________
LABU
Looks like it is going to break 8's this coming week and we could soar!
My gestalt feeling is that it retraces… As it usually does.
Followers
|
40
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
490
|
Created
|
06/26/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |